Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FSHR p.N680S pharmacogenetic study of follitropin alfa in idiopathic male infertility
2010-020240-35Phase 2Completed
- Sponsor
- AOU Policlinico di Modena
- Start
- Jul 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of follitropin alfa in unexplained male infertility (UMI) (2 cohorts), sponsored by AOU Policlinico di Modena. Primary endpoints: Sperm DNA fragmentation index and Patients with improvement in DFI greater than 60%. Started Jul 2010; status: completed.
02
Drugs
follitropin alfa
03
Conditions
unexplained male infertility (UMI)
Beyond the preview
Go deeper on 2010-020240-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020240-35.